Written questions by Maguire.

What assessment his Department has made of the potential impact of providing mobile PSA blood testing clinics in deprived communities on rates of early prostate cancer detection.

Tackling health inequalities is a priority for the Government. Men aged 50 years old or over can ask their general practitioner for a Prostate-Specific Antigen (PSA) test, even if they do not have symptoms. This applies to anyone aged 50 years old or over in any part of England.Screening for prostate cancer is currently not recommended in the United Kingdom. This is because of the inaccuracy of the current best test. Whilst it is recognised that the PSA test can be a valuable diagnostic tool in certain contexts, such as for men who present with symptoms, its limitations mean it is not currently recommended for population-level screening.We are finding the best way to test for prostate cancer, which is why we are investing £16 million towards the Prostate Cancer UK led TRANSFORM screening trial, which is seeking to find better ways of catching prostate cancer in men.The UK National Screening Committee, an independent scientific committee which advises ministers on screening, is also currently reviewing the evidence for both population wide screening and targeted prostate cancer screening. If the UK National Screening Committee makes a positive recommendation regarding screening for prostate cancer, an impact assessment will be produced using the HM Treasury Green Book methodology, which considers wider social and economic impacts.

What assessment his Department has made of the potential impact of implementing nurse-led mobile PSA blood testing clinics in deprived communities on (a) costs to and (b) staff productivity in the NHS.

Tackling health inequalities is a priority for the Government. Men aged 50 years old or over can ask their general practitioner for a Prostate-Specific Antigen (PSA) test, even if they do not have symptoms. This applies to anyone aged 50 years old or over in any part of England.Screening for prostate cancer is currently not recommended in the United Kingdom. This is because of the inaccuracy of the current best test. Whilst it is recognised that the PSA test can be a valuable diagnostic tool in certain contexts, such as for men who present with symptoms, its limitations mean it is not currently recommended for population-level screening.We are finding the best way to test for prostate cancer, which is why we are investing £16 million towards the Prostate Cancer UK led TRANSFORM screening trial, which is seeking to find better ways of catching prostate cancer in men.The UK National Screening Committee, an independent scientific committee which advises ministers on screening, is also currently reviewing the evidence for both population wide screening and targeted prostate cancer screening. If the UK National Screening Committee makes a positive recommendation regarding screening for prostate cancer, an impact assessment will be produced using the HM Treasury Green Book methodology, which considers wider social and economic impacts.

What steps his Department is taking to help increase research into the causes of prostate cancer in men of sub-Saharan African ancestry.

The Department funded National Institute for Health and Care Research (NIHR) funds research and research infrastructure, which supports patients and the public to participate in high-quality research, including clinical research on prostate cancer. NIHR research expenditure for all cancers was £133 million in 2023/24, reflecting its high priority.These investments are pivotal towards efforts to improve cancer prevention, treatment, and outcomes. The TRANSFORM trial is an important example of this. On 19 November 2023, the Government and Prostate Cancer UK announced the £42 million TRANSFORM screening trial to find the best way to screen men for prostate cancer, to find it before it becomes advanced and harder to treat.Prostate Cancer UK is leading the development of the trial with the Government contributing £16 million through the Department. One of the aims of the trial is to address some of the inequalities that exist in prostate cancer diagnosis today. For example, one in four black men will develop prostate cancer, double the risk of other men, and often at a younger age. The trial will ensure that at least 10% of the men who are invited to participate in the trial are black.The NIHR provides an online service called Be Part of Research, which promotes participation in health and social care research by allowing users to search for relevant studies and register their interest. This makes it easier for people to find and take part in health and care research that is relevant to them.The NIHR continues to encourage and welcome applications for research into any aspect of human health, including prostate cancer.

If his Department will undertake a review of intelligence-sharing structures with the US.

The US and the UK have the closest of relationships; our defence, security and intelligence are completely intertwined. No two countries are as close as our two countries, and at a time like this, it would be a mistake to suggest that any weakening of that link is the way forward for security and defence in Europe. As such, the Department has no plans to undertake a review of our intelligence sharing arrangements with the US.

If she will introduce a ban on pavement parking in town centres outside of London.

The Department for Transport has been considering all the views expressed in response to the consultation in 2020 and is currently working through the policy options and the appropriate means of delivering them. As soon as the Government has decided its preferred way forward, we will announce the next steps and publish our formal response. In the meantime, local authorities can make use of existing powers to manage pavement parking.

Food and Rural Affairs, what discussions his Department has had with Thames Water on the use of their emergency loan.

The Government and Ofwat – the financial regulator for the water sector – are carefully monitoring the situation, and Ofwat is working closely with the company to strengthen their long-term financial resilience within the context of its license and broader statutory obligations. Fundamentally it is for the company to solve their issues of financial resilience. It is not for the Government to tell a private company how to manage their finances. It would be inappropriate to comment on ongoing legal proceedings. We prepare for a range of scenarios across our regulated industries – including water – like any responsible Government would.

If her Department will take steps to integrate social prescribing link workers into (a) schools and (b) Young Futures Hubs.

This government is committed to improving mental health support for all children and young people. This is critical to breaking down barriers to opportunity, and helping pupils to achieve and thrive in education. That is why the department has committed to expanding Mental Health Support Teams (MHSTs), so every young person has access to early support to address problems before they escalate. As of April 2024, NHS-funded MHSTs covered 44% of pupils in schools and learners in further education in England, and are expected to cover at least 50% by the end of March 2025.NHS England has recognised that social prescribing is an early intervention approach that can work particularly well for people with low level mental health needs. It has set out a framework for social prescribing link workers operating within or alongside primary care networks. The University of Manchester’s article highlights findings of a pilot on how social prescribing link workers can work effectively to support young people in colleges.It is for schools and colleges to choose the most appropriate support for their students based on their understanding of needs, making links to primary care services in their area and the support they provide to children and young people. We will look at the lessons of the pilot and evidence on social prescribing in exploring future practical resources for schools and colleges, helping them to provide effective early support.Regarding Young Futures Hubs, the staffing of each hub will be co-designed with local stakeholders to meet the needs of their local community and the three overriding objectives of improving opportunities, improving mental health and wellbeing, and reducing crime. Such designs may include a variety of different staffing arrangements including social prescribers and other related professionals.

If he will take steps to increase the level of research into (a) multi-cancer early detection tests and (b) other innovative cancer screening methods.

Research is crucial in tackling cancer, which is why the Department, through the National Institute for Health and Care Research (NIHR), invests over £1.6 billion per year in health research. In 2023/24, the NIHR invested £133 million on cancer research.Our investment plays a crucial role in underpinning the research funded by our partners. Examples of research into multi-cancer early detection tests currently funded by the NIHR in partnership with the Offices for Life Sciences are miONCO-Dx, a novel test which aims to detect 12 of the most lethal and common cancers at an early stage, and Enlighten, which explores a new means of detecting cancerous cells by analysing protein traces in blood samples. The NIHR also co-funds Cancer Data Driven Detection (CD3), a major new national research initiative in partnership with Cancer Research UK, which uses data to revolutionise our understanding of individual cancer risk, and to allow early detection of cancers. On 4 February 2025, the Department announced that nearly 700,000 women across the country will take part in a world-leading trial to test how cutting-edge artificial intelligence tools can be used to catch breast cancer cases earlier. The Early Detection using Information Technology in Health trial is backed by £11 million of Government support via the NIHR. The NIHR continues to encourage and welcome applications for research into any aspect of human health, including early detection and innovative cancer screening methods.

What assessment he has made of the potential impact of increasing capacity for Scottish onshore wind by 700MW between 2030 and 2035 on net zero targets.

We don't consider the increase in capacity planned for Scotland between 2030 and 2035 to have an impact on our ability to reach our net zero targets. The 2035 capacity number for Scotland is based on the National Energy System Operator’s Future Energy Scenarios, which present credible pathways to decarbonise our energy system as we strive towards the 2050 target.

What assessment she has made of the potential implications for her policies of the University of Manchester research entitled The right prescription: Young people, mental health and social prescribing, published on 19 March 2025.

This government is committed to improving mental health support for all children and young people. This is critical to breaking down barriers to opportunity, and helping pupils to achieve and thrive in education. That is why the department has committed to expanding Mental Health Support Teams (MHSTs), so every young person has access to early support to address problems before they escalate. As of April 2024, NHS-funded MHSTs covered 44% of pupils in schools and learners in further education in England, and are expected to cover at least 50% by the end of March 2025.NHS England has recognised that social prescribing is an early intervention approach that can work particularly well for people with low level mental health needs. It has set out a framework for social prescribing link workers operating within or alongside primary care networks. The University of Manchester’s article highlights findings of a pilot on how social prescribing link workers can work effectively to support young people in colleges.It is for schools and colleges to choose the most appropriate support for their students based on their understanding of needs, making links to primary care services in their area and the support they provide to children and young people. We will look at the lessons of the pilot and evidence on social prescribing in exploring future practical resources for schools and colleges, helping them to provide effective early support.Regarding Young Futures Hubs, the staffing of each hub will be co-designed with local stakeholders to meet the needs of their local community and the three overriding objectives of improving opportunities, improving mental health and wellbeing, and reducing crime. Such designs may include a variety of different staffing arrangements including social prescribers and other related professionals.

Food and Rural Affairs, what steps he is taking to ensure that pubs are not charged twice for recycling glass bottles under Extended Producer Responsibility rules.

Packaging Extended Producer Responsibility (pEPR) obligates brands and packaging producers to pay the costs of managing household packaging waste. In most cases, this will not be individual pubs but the business supplying the pub with packaged goods. It is up to individual producers whether to pass these costs on to their customers. The pEPR fees are intended to incentivise producers to use less packaging and to ensure the packaging they do use is environmentally sustainable. For example, where producers use reusable packaging, they will only pay a pEPR fee the first time it is used. Reuse will therefore provide a significant decrease in fees and customers, such as pubs, will see a decrease in waste management costs. Industry is already making progress in this area, the British Beer and Pub Association and ABInbev recently hosted a well-attended glass bottle reuse workshop where UK glass reuse trials were showcased. This included a Greene King trial which started with 25 pubs last year and which will soon be expanded to several hundred pubs, and the multi-retailer glass reuse trial that is due to start in Newport later this year.

What assessment he has made of the potential impact of the number of anaesthetists on maternity care.

There has been no such assessment. Decisions about recruitment are matters for individual National Health Service employers. NHS trusts manage their recruitment at a local level, ensuring they have the right number of staff in place, with the right skill mix, to deliver safe and effective care.We are committed to training the staff we need, including anaesthetists and all other medical specialities, to ensure patients are cared for by the right professional, when and where they need it.We have launched the 10-Year Health Plan which will set out a bold agenda to reform and repair the NHS. A central part of the 10-Year Health Plan will be our workforce and how we ensure we train and provide the staff, technology, and infrastructure the NHS needs to care for patients across our communities.We will publish a refreshed Long Term Workforce Plan to deliver the transformed health service we will build over the next decade, and treat patients on time again.

What steps his Department is taking to prevent (a) stalled and (b) speculative schemes from preventing viable renewable energy projects from progressing.

The government is working closely with Ofgem, National Energy System Operator (NESO) and network companies to reform the connections process and enable advanced projects, that align with our strategic needs, to connect faster. Ofgem is currently considering connection reform proposals from NESO, which include requirements for projects to demonstrate sufficient progress to obtain, and retain, a connection agreement.

What steps he is taking to reduce the late diagnosis of (a) rare and (b) less common cancers.

Improving early diagnosis rates is a key priority for the Government for all cancer types, including rare and less common cancers. We are improving public awareness of cancer signs and symptoms, streamlining referral routes, and increasing the availability of diagnostic capacity through the roll-out of more community diagnostic centres.NHS England runs Help Us Help You campaigns to increase knowledge of cancer symptoms and address barriers to acting on them, to encourage people to come forward as soon as possible to see their general practitioner. The campaigns focus on a range of symptoms as well as encouraging ‘body awareness’ to help people spot symptoms across a wide range of cancers at an earlier point.We are also committed to improving waiting times for cancer treatment, so that people with cancer, including rarer cancers, can get access to the care they need more quickly. The National Health Service has delivered an extra 40,000 operations, scans, and appointments each week, as the first step to ensuring early diagnosis and faster treatment.Finally, the National Cancer Plan will include further details on how we will improve outcomes for cancer patients, as well as speeding up diagnosis and treatment, ensuring patients have access to the latest treatments and technology. The plan will seek to improve every aspect of cancer care, to improve the experiences and outcomes for people with cancer, including rare and less common cancers.

If she will make an assessment of the potential merits of implementing a target for at least 75% of children and young people to be (a) diagnosed and (b) have cancer ruled out within 10 days of their first symptom presentation to a clinician.

We are committed to getting the National Health Service diagnosing cancer earlier and treating it faster so that more patients survive, including children and young people. The forthcoming National Cancer Plan will outline our approach to delivering this.In the meantime, the National Institute for Health and Care Excellence has set out detailed guidance for general practitioners on the symptoms of cancer in children and young people, recommending referral within 48 hours for those presenting with a range of potential cancer symptoms.The Department is also taking steps to improve waiting times for cancer diagnosis and treatment across all cancer patient groups, including children and young people. This will be achieved by delivering an extra 40,000 scans, appointments, and operations each week to ensure that patients are seen and treated as quickly as possible.To further support timely investigation after referral, we are working with the NHS to maximise the pace of the roll-out of additional diagnostic capacity, delivering the final year of the three-year investment plan for establishing community diagnostic centres, with capacity prioritised for cancer.On 4 February 2025, the Department relaunched the Children and Young People Cancer Taskforce. The taskforce will explore a range of issues, including early detection and diagnosis, in order to identify areas of improvement for this patient group.

Whether she has made an assessment of the potential merits of reforming mathematical education to emphasise (a) data, (b) technology and (c) computing.

The government has established an independent Curriculum and Assessment Review, covering ages 5 to 18, chaired by Professor Becky Francis CBE. The Review is looking at all curriculum subjects, including mathematics. It is committed to ensuring the curriculum sufficiently prepares children and young people for future life and work, building the knowledge, skills and attributes to thrive. The Review Group has now published an interim report, which sets out its findings and confirms the key areas for further work. The report can be found here: https://www.gov.uk/government/publications/curriculum-and-assessment-review-interim-report. The report highlights the need for the curriculum to “respond to social and technological change”. The Review Group’s next steps include considering how best to equip young people with “the essential knowledge and skills which will enable them to adapt and thrive in a rapidly changing and artificial intelligence (AI)-enabled world”. The government will respond to the final recommendations in autumn.

Communities and Local Government, whether she has made a recent assessment of the potential merits of Government funding for Local Welfare Assistance.

Local welfare assistance funding is delivered through the Local Government Finance Settlement. The majority of funding in the local government finance settlement is unringfenced recognising that local leaders are best placed to identify local priorities.

What steps he is taking to increase awareness that military compensation should not be treated as income in means tests for statutory support.

The Ministry of Defence and the Department for Work and Pensions (DWP) collaborate closely to ensure the current practice of how their respective schemes and benefits work together, and any proposed changes, are communicated and considered. Advice is available on gov.uk for those seeking further guidance - https://www.gov.uk/guidance/veterans-uk-contact-us The DWP already applies different treatment for Armed Forces compensation payments across the benefit system in comparison to other groups. This reflects the nature of the payments to compensate those who have made significant sacrifices for our country. For example, Universal Credit fully disregards War Pensions and Armed Forces Compensation payments. This means that payments under these Schemes do not impact the eligibility or amount of benefit to which individuals might be entitled. Other social security benefits may partially or fully disregard Armed Forces-related compensation payments. This will be dependent on the type of benefit being considered, as different benefits have different criteria.

What support his Department provides to (a) service personnel and their families and (b) people leaving the services to improve financial resilience.

The Ministry of Defence (MOD) works in close partnership with several financial institutions including three not-for-profit Credit Unions which make up the MOD’s Joining Forces Credit Union initiative. Joining Forces Credit Union provides Service personnel, their partners, families, and dependants, with access face-to-face and online financial awareness briefings to help improve financial resilience with an emphasis on encouraging a savings culture and deterring the use of ‘pay day loan companies’. All Service leavers are entitled to support from the Career Transition Partnership (CTP). Service leavers are encouraged to attend The Financial Aspects of Resettlement (FAR) brief which is a single day course designed to help them access financial awareness and long-term planning information, tax, pensions, and benefits advice. There are 11 resettlement hubs around the UK, located in areas where the majority of Service personnel choose to settle.

What assessment he has made of the potential implications for his policies of the Institute of Cancer Research's report entitled Cost-utility analysis of adding abiraterone acetate plus prednisone/prednisolone to long-term hormone therapy in newly diagnosed advanced prostate cancer in England: Lifetime decision model based on STAMPEDE trial data, published on 2 June 2022.

Abiraterone has a United Kingdom marketing authorisation for the treatment of metastatic hormone-relapsed prostate cancer before chemotherapy is indicated, and for castration-resistant metastatic prostate cancer previously treated with a docetaxel-containing regimen. It has been recommended by the National Institute for Health and Care Excellence (NICE) for use within these licensed indications. It is currently routinely funded by the National Health Service in England for its NICE-recommended indications, in line with the legal requirement.Abiraterone does not have a UK marketing authorisation for use in the treatment of hormone sensitive, non-metastatic prostate cancer. Decisions on routine NHS funding for cancer medicines outside of their licensed indications, or “off-label”, are taken by NHS England through its specialised commissioning function, taking into account the available evidence and affordability.NHS England considered abiraterone as an off-label treatment for hormone sensitive, non-metastatic prostate cancer through its clinical policy development process in 2024/25. Through this process, NHS England confirmed that there was sufficient supporting evidence to support the routine commissioning of abiraterone in this indication, and it was ranked in the highest priority level. However, NHS England could not identify the necessary recurrent funding to support commissioning of abiraterone, or any other treatments within the prioritisation round.